Format

Send to

Choose Destination
J Infect Dis. 2018 Jul 2;218(3):347-354. doi: 10.1093/infdis/jiy103.

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Author information

1
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
2
Division of Microbiology and Infectious Diseases.
3
Division of Allergy, Immunology, and Transplantation.
4
Vaccine Research Center.

Abstract

A priority for the National Institute of Allergy and Infectious Diseases is development of a universal influenza vaccine providing durable protection against multiple influenza strains. NIAID will use this strategic plan as a foundation for future investments in influenza research.

PMID:
29506129
PMCID:
PMC6279170
[Available on 2019-08-01]
DOI:
10.1093/infdis/jiy103

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center